Moderna to present Covid-19 vaccine data in older people at industry meeting

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

Triggering neutralising antibodies in older patients is important as these patients are some of the most severely affected by Covid-19

Moderna will present safety data on Wednesday from an early trial that provides the first glimpse of how its Covid-19 vaccine stimulates the immune system in older people.

The company will present “new interim safety and immunogenicity data from the cohorts of older adults” from its phase 1 trial, according to a statement. The results will be presented to the US Center for Disease Control and Prevention’s Advisory Committee on Immunisation Practices. The company earlier published data from the same trial showing that the vaccine produced neutralising antibodies against the coronavirus in younger adults. .

The Moderna vaccine is now in a large, final-stage trial in the US, with results possible by late fall. Moderna shares rose as much as 3.1% in premarket trading in New York.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 12. in İT
 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

WATCH: How Covid-19 sent Absa’s earnings slidingFinancial director Jason Quinn talks to Business Day TV about the bank’s performance
Fonte: BDliveSA - 🏆 12. / 63 Leggi di più »